missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Zenocutuzumab Humanized Recombinant Human Monoclonal Antibody

Description
Endotoxin level <0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.
Zenocutuzumab is under investigation in clinical trial NCT03321981 (MCLA-128 With Trastuzumab/chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer).
Specifications
Specifications
| Antigen | Zenocutuzumab Humanized |
| Applications | ELISA, SDS-Page |
| Classification | Recombinant Monoclonal |
| Concentration | 1.75 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with no preservative; pH 7.4 |
| Gene Alias | MCLA-128; PB4188; R040517 |
| Host Species | Human |
| Immunogen | Human ERBB2/ERBB3. |
| Purification Method | Protein A/G |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?